Proving the safety and efficacy of investigational products is a challenging and costly endeavour - and ignoring the risks associated with poor medication adherence risks corroding the integrity of research.
Over the years, a large body of evidence has emerged linking poor adherence to null findings, unduly large sample sizes, the need for dose modifications, and in some cases, trial failure.
This recording hosted by AARDEX Group features Matt Bolton, Director of Clinical Trial Supply Technology Innovation, and Ning You, Director, Product and Technology Development, discussing:
Industry developments in context of utilizing smart packages and digital health technology to improve medication adherence
Practical, evidence-backed digital solutions for mitigating the risks of poor adherence
What the future holds for medication adherence management
Meet the Panel
Matt Bolton
Director of Clinical Trial Supply Technology Innovation
-1.png?width=600&height=600&name=Bernard%20Vrijens%20Ph.D%20(1)-1.png "Bernard Vrijens Ph.D (1)-1")
